石斛抗炎药理机制的系统综述
该综述基于PRISMA 2020指南检索多数据库,系统总结近六年石斛属药用植物及其活性成分的抗炎药理研究。八种药用石斛的多糖、生物碱、黄酮等成分通过调控NF-κB、MAPK/NF-κB、TLR4/NF-κB、PI3K/AKT、Nrf2/HO-1、JAK/STAT、AMPK/SIRT1等多条信号通路发挥抗炎作用。
要点
- 石斛多种活性成分可多靶点调控炎症信号通路。
- 八种药用石斛显示广谱抗炎潜力,涉及多器官机制。
- 临床转化需优先建立质量控制与多组学系统研究。
核心结论
- 药用石斛通过多靶点、多通路、多器官机制发挥广谱抗炎作用,是有前景的民族药理资源。
研究设计与样本
- 系统综述遵循PRISMA 2020指南,采用预设布尔检索策略,检索Web of Science、PubMed、Elsevier、ScienceDirect、Scopus、CNKI、万方、百度学术和Google Scholar,无语言限制。
主要发现
- 八种药用石斛及其多糖、生物碱、黄酮、联苄、多酚和芪类成分可调控NF-κB、MAPK/NF-κB、TLR4/NF-κB、PI3K/AKT、Nrf2/HO-1、JAK/STAT和AMPK/SIRT1等信号通路。
- 石斛活性成分具有与常规药物治疗协同用于精准医学的潜力。
临床怎么用
- 可将石斛作为多靶点天然抗炎资源,考虑与常规药物联合用于炎症性疾病。
局限性
- 需建立标准化质量控制体系并优先解析核心活性成分结构。
- 需加强系统药代动力学和生物利用度研究。
- 需开展精准协同递送制剂研发及严格的安全性评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: In Traditional Chinese Medicine (TCM), Dendrobium species have long been used to alleviate various inflammatory conditions, particularly those characterized by Yin deficiency with internal heat and stomach deficiency-heat, including impaired fluid production, stomach Qi dysfunction, and poor appetite. The inflammatory response is regulated by multiple signaling pathways that drive disease pathogenesis, making these pathways promising targets for anti-inflammatory therapy. Medicinal Dendrobium, enriched with anti-inflammatory bioactive constituents, exhibits substantial systemic anti-inflammatory activity. Its growing research interest stems from favorable properties such as low toxicity, broad therapeutic efficacy, and minimal risk of drug resistance. AIM OF THE STUDY: Medicinal Dendrobium and its bioactive constituents have demonstrated significant anti-inflammatory properties, underscoring their pharmacological potential. Nevertheless, substantial efforts remain an urgent priority to advance the translation of basic research findings into clinical applications. Therefore, pharmacological studies published within the past six years were systematically reviewed to elucidate the mechanisms by which Medicinal Dendrobium and its bioactive constituents modulate inflammatory processes, thereby evaluating their potential as multi-targeted natural anti-inflammatories. This will facilitate the translation of anti-inflammatory research on medicinal Dendrobium from basic research to clinical investigation, thereby laying a solid foundation for its eventual clinical application in managing inflammatory diseases. MATERIALS AND METHODS: A literature search and screening strictly followed the PRISMA 2020 guidelines and employed a predefined Boolean strategy. A comprehensive search was conducted across Web of Science, PubMed, Elsevier, ScienceDirect, Scopus, CNKI, Wanfang Data, Baidu Scholar, and Google Scholar. No language restrictions were applied; this review includes key findings from Chinese-language literature. The predefined keywords included "Dendrobium," "Shihu," "bioactive constituents," "anti-inflammatory," "cytokines," "signaling pathways," as well as their corresponding Chinese terms. Taxonomic validation was conducted using the World Flora Online (http://www.worldfloraonline.org) and the Medicinal Plant Names Services (http://mpns.kew.org) databases. RESULTS: Eight Medicinal Dendrobium species and their bioactive constituents-such as polysaccharides, alkaloids, flavonoids, bibenzyls, polyphenols and stilbenoids-exert anti-inflammatory effects by modulating multiple signaling cascades, including NF-κB, MAPK/NF-κB, TLR4/NF-κB, PI3K/AKT, Nrf2/HO-1, JAK/STAT, and AMPK/SIRT1 pathways, indicating their multi-target therapeutic potential for inflammatory diseases. This review further underscores the innovative role of Dendrobium in regulating these pathways and its potential for integration with conventional pharmacological treatments, supporting its synergistic use in precision medicine. CONCLUSIONS: Medicinal Dendrobium represents a promising ethnopharmacological resource, exhibiting broad-spectrum anti-inflammatory effects through multi-target, multi-pathway, and multi-organ mechanisms. To advance its modernization, therapeutic development, and clinical translation, future research should prioritize several key directions: establishing standardized quality control system and prioritizing the structures of core bioactive constituents; applying a multi-omics approach combined with artificial intelligence-assisted modeling, network pharmacology and advanced molecular imaging techniques to systematically map its systemic anti-inflammatory regulatory network; strengthening systematic pharmacokinetic and bioavailability studies; exploring precision and synergy delivery formulations; and conducting rigorous assessments of safety profiles and side-effect management. By focusing on these priorities, research can further elucidate the systemic anti-inflammatory mechanisms of medicinal Dendrobium, thereby bridging its traditional use with contemporary precision medicine, and supporting integrated interventions for complex inflammatory diseases.
引用
- Yang BQ, Tang CY, Zhi TT, et al. Anti-inflammatory properties of Dendrobium: A systematic review of pharmacological mechanisms. J Ethnopharmacol. 2026. PMID: 41619861. doi:10.1016/j.jep.2026.121234
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。